Global 3D Bioprinting Equipment Market Professional Survey Report 201 Antidiabetic-SGLT-2-Inhibitor-Market-Report-2017 | Page 5

10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.6.2.1 Canagliflozin
10.6.2.2 Empagliflozin
10.6.3 AstraZeneca Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin
(2011-2016)
10.6.4 Main Business/Business Overview
10.7 Boehringer Ingelheim
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.7.2.1 Canagliflozin
10.7.2.2 Empagliflozin
10.7.3 Boehringer Ingelheim Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin
(2011-2016)
10.7.4 Main Business/Business Overview
10.8 GlaxoSmithKline
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.8.2.1 Canagliflozin
10.8.2.2 Empagliflozin
10.8.3 GlaxoSmithKline Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin
(2011-2016)
10.8.4 Main Business/Business Overview
10.9 Pfizer
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Specification
10.9.2.1 Canagliflozin
10.9.2.2 Empagliflozin
10.9.3 Pfizer Antidiabetic SGLT-2 Inhibitor Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Takeda Pharmaceuticals
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Antidiabetic SGLT-2 Inhibitor Product Type, Application and Spec